Clinical Trial Management Systems: Features and Selection Criteria

Clinical trial management systems (CTMS) are software platforms designed to support the planning, tracking, and oversight of clinical research studies. These systems help research teams manage patient enrollment, site activities, regulatory documents, and data collection across the trial lifecycle. For students, researchers, and life-science professionals evaluating software options, understanding the core features of CTMS, electronic trial master files (eTMF), and electronic patient-reported outcomes (ePRO) tools is essential for making informed purchasing decisions. This article provides a feature comparison framework and a practical checklist for evaluating vendors, with attention to integration capabilities, usability, and regulatory considerations.

The Role of CTMS in Modern Clinical Research

Clinical trials involve complex coordination across multiple sites, investigators, regulatory bodies, and data systems. A CTMS centralizes operational data so that trial managers can monitor progress, identify bottlenecks, and maintain compliance with study protocols. The practical value of these systems lies in their ability to replace fragmented spreadsheets and paper-based tracking with a unified platform that supports real-time visibility into trial operations.

Electronic systems in clinical research enable streamlined data transfer, remote enrollment capabilities, greater transparency of trial conduct, improved research documentation, and clearer audit trails [12]. These capabilities matter for research teams because they reduce administrative burden and support data integrity throughout the study. For oncology nurses and other clinical research staff, electronic systems move beyond traditional data collection and may enhance the successful completion and adherence of clinical trials while maintaining participant safety [12].

A CTMS typically supports the following operational functions:

• Site selection and activation tracking
• Patient recruitment and enrollment management
• Visit scheduling and participant calendars
• Regulatory document management
• Budget and contract management
• Adverse event reporting coordination
• Monitoring visit tracking
• Metrics and performance dashboards

The scope of a CTMS can vary significantly between vendors. Some systems focus narrowly on patient enrollment and visit tracking, while others offer full lifecycle management including financial tracking and regulatory compliance features. Understanding these differences is critical when evaluating whether a system meets your specific research program needs.

Core CTMS Features to Evaluate

When assessing clinical trial management systems, several feature categories deserve close examination. Each category affects how effectively your team can manage trials and whether the system will integrate with your existing research infrastructure.

Patient Enrollment and Tracking

Patient recruitment remains one of the most challenging aspects of clinical trial execution. A CTMS should provide tools for tracking potential participants from initial screening through enrollment and study completion. Look for features that support:

• Screening logs and eligibility checklists
• Enrollment targets and actual enrollment tracking
• Participant status management across study phases
• Retention tracking and visit completion monitoring
• Communication logs for participant interactions

The ability to track enrollment metrics in real time allows trial managers to identify underperforming sites and adjust recruitment strategies promptly. Systems that integrate with electronic medical records can further streamline the identification of eligible participants, though this integration requires careful attention to data privacy and security requirements.

Site Management and Monitoring

Multi-site trials introduce significant coordination complexity. A CTMS should enable centralized oversight of all participating sites, including:

• Site qualification and activation status
• Regulatory document submission tracking
• Monitoring visit scheduling and reporting
• Site performance metrics and benchmarking
• Issue tracking and resolution workflows

Effective site management features help sponsors and contract research organizations identify sites that may need additional support or training. Machine learning approaches are being developed to predict site risk using data from CTMS, eTMF, and ClinicalTrials.gov, with the goal of guiding site selection and qualification visit decisions [17]. While these predictive tools are still emerging, they point to the growing importance of data-driven site oversight.

Document Management and eTMF Integration

The trial master file contains essential documents that demonstrate regulatory compliance and study integrity. Electronic trial master file systems digitize these records, making them searchable and accessible to authorized team members. Key eTMF features include:

• Document version control and approval workflows
• Regulatory submission tracking
• Audit trail documentation
• Access controls and permission management
• Expiration date tracking for essential documents

Entering content from manually completed forms into an eTMF database is a tedious and time-consuming task, though automatic transcription approaches using optical document recognition and large language models show promise for reducing this burden [16]. When evaluating eTMF functionality, consider whether the system supports automated data extraction and how well it handles the document types your studies typically generate.

Reporting and Analytics

Trial oversight requires timely access to accurate metrics. A CTMS should offer customizable dashboards and reports that address:

• Enrollment progress against targets
• Data entry timeliness and completeness
• Query resolution times
• Protocol deviation trends
• Site performance comparisons
• Budget utilization

The ability to generate reports without requiring specialized technical skills is important for busy research teams. Some systems offer built-in analytics while others integrate with external business intelligence tools. Consider which reporting capabilities your team actually needs and whether the vendor's standard reports align with your institutional requirements.

Electronic Patient-Reported Outcomes (ePRO) Systems

Electronic patient-reported outcomes tools allow study participants to report symptoms, quality of life measures, and other health data directly through digital interfaces such as mobile apps, tablets, or web portals. These systems capture patient experiences in real time, reducing recall bias and improving data completeness compared with paper-based questionnaires.

Key ePRO Features

When evaluating ePRO systems, consider the following features:

• Support for multiple questionnaire formats and validated instruments
• Offline data collection for participants with limited connectivity
• Automated reminders and alerts for missed assessments
• Integration with the CTMS for consolidated data views
• Compliance tracking for scheduled assessments
• Data validation rules to minimize entry errors

The choice of ePRO delivery method matters for participant adherence. Some participants may prefer mobile apps while others respond better to web-based portals or interactive voice response systems. A flexible ePRO platform that supports multiple modes of data collection can accommodate diverse participant preferences and improve data completeness.

Integration Considerations

ePRO data must flow into the trial database for analysis and safety monitoring. Evaluate whether the ePRO vendor offers direct integration with your CTMS or electronic data capture system, or whether data must be transferred through intermediate files. Direct integration reduces the risk of data transfer errors and provides trial managers with a more complete view of participant status.

Electronic Trial Master File (eTMF) Systems

The eTMF serves as the centralized repository for trial documentation, replacing physical binders with a searchable electronic archive. Regulatory authorities expect sponsors to maintain complete and accurate trial master files, and eTMF systems help organizations meet these expectations through structured document management.

Essential eTMF Capabilities

A robust eTMF should provide:

• Document classification according to regulatory standards
• Version history and audit trails
• Role-based access controls
• Electronic signatures for approvals
• Automated notifications for document expirations
• Inspection readiness reporting

The integration between eTMF and CTMS is particularly important. When these systems share data, trial managers can see the relationship between operational activities and documentation status. For example, a site activation milestone in the CTMS should trigger the appropriate document requirements in the eTMF.

Transcription and Data Entry Challenges

Manual data entry into eTMF systems remains a significant operational burden for research teams. Studies evaluating automatic transcription of handwritten forms have found that different approaches work best for different column types in table-based documents, and that drastic time savings compared with manual transcription are possible [16]. When evaluating eTMF systems, ask vendors about their capabilities for automated document processing and whether these features support the document formats common in your therapeutic areas.

Integration with Hospital and Enterprise Systems

Clinical trials conducted in hospital settings face unique challenges related to institutional infrastructure and record-keeping. An integrated CTMS can address these challenges by connecting with existing hospital systems to support comprehensive trial oversight.

Real-World Integration Example

A study of an integrated CTMS established at a large teaching hospital demonstrated the value of connecting trial management with other institutional systems [8]. The system integrated with the human research audit system, biobank management system, biological sample management system, enterprise resource system, institutional review, and single sign-on system [8]. This integration supported effective tracking and monitoring of clinical studies while providing controlled access according to defined policies [8].

The scale of operations supported by this integrated system illustrates the potential of CTMS in large research enterprises. The system managed 913 trials with 53,969 subjects enrolled, supporting 851 products developed, 159 investigators, 784 new drugs and indications, 98 devices, and 98 new medical technologies, with a total budget of approximately 106.9 million US dollars [8]. The increasing number of trials and subjects enrolled indicates the robustness and efficacy of the integrated approach [8].

Integration Points to Consider

When evaluating CTMS vendors, ask about integration capabilities with:

• Electronic medical record systems
• Institutional review board systems
• Biobank and sample management systems
• Enterprise resource planning systems
• Single sign-on authentication
• Clinical data management systems
• Safety and pharmacovigilance databases

The depth of integration varies considerably between vendors. Some offer pre-built connectors for common hospital systems, while others require custom development through application programming interfaces. Consider your institution's existing technology stack and whether the vendor has experience integrating with similar systems.

Usability and Human-Computer Interaction

The usability of a CTMS directly affects adoption by research staff and the quality of data entered into the system. Systems that are difficult to navigate or require extensive training may lead to incomplete data entry, user frustration, and reduced compliance with study procedures.

Usability Research Findings

Research on human-computer interaction issues in clinical trial management systems has identified usability as a critical factor in system success [22]. Comparative usability studies of multiple CTMS platforms have shown that systems differ significantly in how easily users can complete common tasks [23]. These differences matter because research coordinators and nurses interact with CTMS systems daily, and inefficient workflows can consume substantial staff time.

Usability Evaluation Approach

When evaluating CTMS vendors, consider conducting structured usability assessments that include:

• Task completion testing with representative users
• Time-to-task measurements for common operations
• User satisfaction surveys
• Error rate tracking during data entry
• Training time requirements

Ask vendors for demonstration environments where your team can test the system with realistic scenarios. Pay attention to how many clicks are required for common tasks, whether the interface provides clear feedback, and how easily users can recover from errors.

Blockchain and Emerging Technologies in CTMS

Emerging technologies are being explored to address persistent challenges in clinical trial management, including data integrity, security, and transparency. Blockchain technology has been investigated as a potential foundation for re-engineering clinical trial management systems [21]. The design and development of blockchain-based CTMS platforms represents an active area of research, with case studies examining the feasibility of distributed ledger approaches for trial data management [21].

When evaluating CTMS vendors, consider whether their technology roadmap includes emerging capabilities such as:

• Blockchain-based audit trails
• Decentralized data storage
• Smart contract automation for trial workflows
• Enhanced data provenance tracking

These features may offer future benefits for data integrity and regulatory compliance, though they remain relatively new in the clinical trial software market. Focus on demonstrated capabilities instead of promises of future functionality.

Gamification and Engagement Features

Clinical trials are lengthy and operationally demanding, which can lead to low enthusiasm and disengagement among site teams [18]. Some trial coordinating centers have successfully implemented gamification strategies to enhance engagement and motivation [18].

Gamification Applications

Gamification in clinical trial systems involves translating ordinary work tasks into a fun thematic framework using game design elements such as points, competition, and recognition [18]. Performance indicators extracted from trial data platforms can be converted into point-based scoring systems, with gamified strategies integrated into trial start-up and enrollment phases [18].

Research has demonstrated successful gamification of start-up tasks across seven trials and enrollment tasks across nine trials [18]. Start-up tasks were similar enough that one game could fit multiple trials, while enrollment games required customization to address protocol-specific challenges and periods of suboptimal performance [18].

Considerations for Gamification Features

When evaluating CTMS platforms, consider whether gamification features align with your team culture and trial requirements. Gamification can be valuable for:

• Accelerating site activation timelines
• Improving patient recruitment performance
• Enhancing protocol compliance
• Increasing data quality metrics

However, gamification is not appropriate for all settings. Some research teams may find competitive elements distracting or inappropriate for serious clinical work. Evaluate whether the vendor's gamification features can be customized or disabled based on your preferences.

At a Glance: CTMS Feature Comparison

The following table summarizes key features to compare when evaluating clinical trial management systems:

Vendor Selection Checklist

Use the following checklist when evaluating CTMS, eTMF, and ePRO vendors. Document your findings for each criterion and compare responses across vendors.

Functional Requirements Assessment

• Does the system support your trial types (interventional, observational, device, drug)?
• Can the system handle your expected trial volume and number of sites?
• Does the system support your therapeutic areas and protocol complexity?
• Are ePRO features included or available as an add-on module?
• Does the eTMF functionality meet your regulatory documentation requirements?

Technical Requirements Assessment

• What are the system architecture and hosting options (cloud, on-premises, hybrid)?
• Does the system support single sign-on integration with your institution?
• What application programming interfaces are available for custom integrations?
• How does the system handle data backup and disaster recovery?
• What are the system performance and uptime guarantees?

Usability Assessment

• How long does training take for new users?
• What is the typical time to complete common tasks such as participant enrollment or document upload?
• Does the vendor provide a test environment for hands-on evaluation?
• What is the quality of user documentation and help resources?
• How responsive is customer support?

Regulatory and Compliance Assessment

• Does the system support compliance with applicable regulations for electronic records and signatures?
• What audit trail capabilities are included?
• How does the system manage user access and permissions?
• Does the vendor provide validation documentation for the system?
• How are software updates and patches managed?

Cost Assessment

• What is the pricing model (per user, per trial, subscription, perpetual license)?
• What implementation and training costs are included?
• What are the ongoing maintenance and support fees?
• Are there additional costs for integrations or custom development?
• What is the expected total cost of ownership over three to five years?

Implementation and Assessment Steps

Successful CTMS implementation requires structured planning and execution. Follow these steps to assess your needs and implement a system effectively.

Step 1: Define Requirements

Begin by documenting your research program's current workflows and identifying pain points. Interview research coordinators, nurses, data managers, and principal investigators to understand their needs. Create a requirements document that distinguishes between essential features and nice-to-have capabilities.

Step 2: Conduct Market Research

Identify vendors that serve your therapeutic areas and institution type. Request demonstrations and product documentation. Use the feature comparison table in this article to structure your evaluation. Consider attending industry conferences or webinars to learn about emerging capabilities.

Step 3: Evaluate Vendor Capabilities

Score each vendor against your requirements using a weighted scoring system. Prioritize features that address your most significant operational challenges. Consider the vendor's track record with similar institutions and their responsiveness during the evaluation process.

Step 4: Pilot Testing

Before full implementation, conduct a pilot test with a single trial or a limited number of users. This allows you to identify workflow issues and training needs before scaling to the full research program. Collect feedback from pilot users and address concerns before proceeding.

Step 5: Plan Implementation

Develop a detailed implementation plan that includes:

• Data migration from existing systems
• System configuration and customization
• Integration with institutional systems
• User training and certification
• Go-live timeline and contingency planning
• Post-implementation support and optimization

Step 6: Monitor and Optimize

After implementation, track system usage and user satisfaction. Monitor key performance indicators such as data entry timeliness, query resolution times, and enrollment progress. Schedule regular reviews with users to identify improvement opportunities and ensure the system continues to meet evolving needs.

Records and Measurements

Maintaining accurate records of CTMS performance helps research programs demonstrate the value of their technology investments and identify areas for improvement.

Key Performance Indicators

Track the following metrics to assess CTMS effectiveness:

• Enrollment rate compared with targets
• Time from site activation to first participant enrolled
• Data entry timeliness (percentage of forms entered within required timeframe)
• Query resolution time
• Protocol deviation rate
• Participant retention rate
• Document completion rate in eTMF
• User satisfaction scores

Measurement Methods

Collect these metrics through:

• System-generated reports and dashboards
• Periodic user surveys
• Audit trail analysis
• Comparison with pre-implementation baseline data

Regular measurement allows research programs to quantify the benefits of their CTMS investment and make data-driven decisions about system optimization or replacement.

Common Failure Patterns in CTMS Implementation

Understanding common failure patterns can help research programs avoid costly mistakes when implementing or upgrading clinical trial management systems.

Inadequate Requirements Definition

Many CTMS implementations fail because organizations select systems without clearly defining their requirements. This leads to mismatches between system capabilities and operational needs. Avoid this by investing time in requirements documentation before vendor selection.

Poor User Adoption

Even well-designed systems fail if users do not adopt them. Common causes of poor adoption include:

• Insufficient training
• Complicated workflows that slow down daily tasks
• Lack of perceived benefit for users
• Resistance to change from established processes

Address adoption challenges through comprehensive training, workflow optimization, and clear communication about the benefits of the new system.

Integration Difficulties

CTMS systems that cannot integrate with existing institutional systems create data silos and duplicate data entry. Integration challenges are particularly common in hospital settings where multiple systems must share data. Evaluate integration capabilities carefully before selecting a vendor.

Underestimating Data Migration Complexity

Moving historical trial data from spreadsheets or legacy systems into a new CTMS is often more complex than anticipated. Data quality issues, inconsistent formats, and missing information can delay implementation. Plan for data cleaning and validation as part of the migration process.

Insufficient Ongoing Support

CTMS implementation is not a one-time project. Systems require ongoing configuration, updates, and user support. Organizations that do not allocate resources for ongoing system management may find that the system becomes outdated or underutilized over time.

Limitations and Considerations

Clinical trial management systems offer significant benefits, but they also have limitations that research programs should understand.

Data Quality Depends on User Input

A CTMS is only as good as the data entered into it. Incomplete or inaccurate data entry undermines the value of the system for trial oversight and reporting. Research programs must invest in training and quality control processes to ensure data accuracy.

System Complexity Can Create Burden

While CTMS systems aim to streamline trial management, they can also introduce complexity. Users may need to navigate multiple screens to complete tasks that were simpler in paper-based systems. Careful workflow design and usability testing can mitigate this challenge.

Integration Limitations

Despite advances in system integration, seamless data flow between CTMS, EMR, ePRO, and other systems remains challenging. Research programs may need to accept some manual data transfer or invest in custom integration development.

Regulatory Considerations

Clinical trial software must comply with applicable regulations for electronic records, electronic signatures, and data integrity. The specific requirements depend on the regulatory jurisdiction and the type of research being conducted. Work with your institutional compliance team to ensure that selected systems meet applicable standards.

Cost Considerations

CTMS systems represent a significant investment, particularly for smaller research programs. Beyond license fees, organizations must budget for implementation, training, integration, and ongoing support. Conduct a thorough cost-benefit analysis before committing to a system.

Safety and Regulatory Context

Clinical trial management systems operate within a complex regulatory environment designed to protect research participants and ensure data integrity.

Participant Safety Monitoring

CTMS systems support participant safety through:

• Adverse event tracking and reporting workflows
• Protocol deviation documentation
• Safety data integration with pharmacovigilance systems
• Real-time alerts for safety signals

These features help research teams identify and respond to safety concerns promptly. The importance of robust safety monitoring is evident across therapeutic areas, from cardiovascular research to oncology trials [7][11].

Data Integrity Requirements

Regulatory authorities expect clinical trial data to be accurate, complete, and verifiable. CTMS systems support data integrity through:

• Audit trails that document all system activities
• Access controls that restrict data modification to authorized users
• Validation documentation that demonstrates system reliability
• Electronic signatures that authenticate approvals

Inspection Readiness

Sponsors and research sites must be prepared for regulatory inspections. CTMS and eTMF systems support inspection readiness by:

• Maintaining complete and organized trial documentation
• Providing searchable access to essential documents
• Generating inspection-ready reports
• Demonstrating compliance with applicable regulations

Professional Escalation Criteria

Research teams should escalate concerns to appropriate authorities when they encounter:

• Serious or unexpected adverse events
• Protocol violations that compromise participant safety
• Data integrity issues that cannot be resolved locally
• Regulatory compliance concerns
• System failures that affect trial oversight

Each research program should have clear escalation procedures that define when and how to report concerns to institutional review boards, data safety monitoring boards, regulatory authorities, and other oversight bodies.

Frequently Asked Questions

What is the difference between a CTMS and an electronic data capture system?

A clinical trial management system focuses on operational aspects of trial conduct, including patient enrollment, site management, and regulatory document tracking. An electronic data capture system focuses on collecting clinical data from study participants, such as laboratory results, vital signs, and outcome assessments. Many organizations use both types of systems, with the CTMS managing trial operations and the EDC system managing clinical data. Some vendors offer integrated platforms that combine these functions.

How does ePRO data integrate with the main trial database?

ePRO systems collect patient-reported data through digital interfaces and transmit this data to the trial database. Integration can occur through direct system-to-system connections or through data file transfers. Direct integration provides real-time data availability and reduces the risk of transfer errors. When evaluating ePRO systems, ask vendors about their integration capabilities with your CTMS and electronic data capture systems.

What is database lock in clinical trials?

Database lock is the process of finalizing the clinical trial database after all data has been entered, cleaned, and verified. Once the database is locked, no further changes are permitted without formal documentation and approval. Database lock is a critical milestone that precedes statistical analysis and study reporting. CTMS systems can help track the activities leading to database lock, including data query resolution and data quality reviews.

How long does it take to implement a CTMS?

Implementation timelines vary based on system complexity, institutional requirements, and the scope of integration needed. Simple implementations with limited integration may take several months, while complex implementations involving multiple system integrations can take a year or more. Factors that affect implementation time include data migration requirements, user training needs, and the availability of institutional resources for the project.

What training do research staff need for CTMS use?

Training requirements depend on the system complexity and the user's role. Research coordinators and data managers typically need comprehensive training on system workflows, while principal investigators may need only basic training for their oversight responsibilities. Most vendors offer training programs that can be customized to institutional needs. Plan for initial training at implementation and refresher training as system updates are released.

How do CTMS systems support multi-site trials?

CTMS systems support multi-site trials by providing centralized oversight of all participating sites. Trial managers can track site activation status, enrollment progress, regulatory document submission, and monitoring visit completion across all sites from a single dashboard. Site-specific performance metrics allow managers to identify sites that may need additional support or training.

What should be included in a CTMS vendor contract?

A CTMS vendor contract should address system functionality, implementation timelines, training requirements, ongoing support, data ownership, security and privacy obligations, regulatory compliance responsibilities, and service level agreements. Work with your institutional legal and procurement teams to ensure that the contract protects your organization's interests and addresses applicable regulatory requirements.

How do emerging technologies like artificial intelligence affect CTMS?

Artificial intelligence is being explored for various CTMS applications, including site risk prediction, document processing, and data quality monitoring. Machine learning approaches have shown promise for predicting site performance using data from CTMS and other trial systems [17]. While these capabilities are still evolving, they point to the future direction of clinical trial management software. When evaluating vendors, ask about their artificial intelligence roadmap and how these features might benefit your research program.

Related Articles

• Digital Droplet PCR (ddPCR) for Absolute Quantification of Swine Enteric Coronaviruses in Fecal and Oral Fluid Samples: Analytical Sensitivity and Clinical Utility
• Multiplex Real-Time RT-PCR for Differential Diagnosis of Canine Infectious Respiratory Disease Complex (CIRDC): Panel Design, Validation, and Clinical Utility
• Clinical Biochemistry and Urinalysis
• Laboratory Equipment Calibration: A Comprehensive Management Guide
• Establishing Reference Intervals in Veterinary Clinical Chemistry

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• PubMed. National Library of Medicine.
• Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium.. Journal of the American College of Cardiology, 2015.
• Integrated Clinical Trial Management System: Establishment and Efficiency Assessment.. Biological & pharmaceutical bulletin, 2025.
• Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.. Stroke, 2021.
• Dengue Fever: Causes, Complications, and Vaccine Strategies.. Journal of immunology research, 2016.
• Brain immunology and immunotherapy in brain tumours.. Nature reviews. Cancer, 2020.
• Oncology Research: Clinical Trial Management Systems, Electronic Medical Record, and Artificial Intelligence.. Seminars in oncology nursing, 2020.
• Breast cancer nursing interventions and clinical effectiveness: a systematic review.. BMJ supportive & palliative care, 2020.
• Assessment and management of agitation in psychiatry: Expert consensus.. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2016.
• Correction: One hundred years of BCG: the journey of tuberculosis vaccination in Brazil.. 2026.
• Transcription of Handwritten Forms for Medical Study Documentation.. 2025.
• Machine learning for site risk prediction in clinical trials: development, external validation, and operational application in site qualification.. 2026.
• Building games into multicenter clinical trial systems to boost trial engagement.. 2026.
• Interleukin-2 and Tretinoin for Myeloproliferative Neoplasms and to Target Type 1 Calreticulin-Driven Neoplasms: Advancements in Immune Regenerative Medicine.. 2026.
• Initial Experiences with Invasive Meningococcal Disease: Insights from Survivors and Their Caregivers.. 2024.
• Re-engineering a Clinical Trial Management System Using Blockchain Technology: System Design, Development, and Case Studies. Journal of Medical Internet Research, 2022.
• Human computer interaction issues in Clinical Trials Management Systems.. AMIA Annual Symposium Proceedings AMIA Symposium AMIA Symposium, 2006.
• Usability comparison of three clinical trial management systems.. AMIA Annual Symposium Proceedings AMIA Symposium AMIA Symposium, 2005.
• Continuous turing machine: Real function computability and iteration issues. Applied Mathematics and Information Sciences, 2014.

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.